Clinical Trials Logo

Filter by:
NCT ID: NCT01910389 Terminated - Heart Failure Clinical Trials

Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure

PITCH-HF
Start date: November 2013
Phase: Phase 3
Study type: Interventional

This study is a multi-center, prospective, randomized, double blind, placebo-controlled clinical trial. Subjects in the study will be adults with New York Heart Association (NYHA) Class II-IV heart failure (HF) due to left ventricular systolic dysfunction (LVSD), left ventricular ejection fraction (LVEF) <0.40, and secondary pulmonary hypertension (PH). The purpose of the study is to evaluate the safety, effectiveness, and effects of tadalafil compared to placebo on the subjects' functional capacity / quality of life.

NCT ID: NCT01909908 Terminated - Clinical trials for Foot Ulcer, Diabetic

ECM and Blood Components for Wound Healing

Start date: February 2013
Phase: N/A
Study type: Interventional

The Extracellular Matrix (ECM) and Blood Components for Wound Healing feasibility study is a clinical trial approved by Health Canada to study the safety of extracellular matrix (ECM) and autologous blood products in wound healing.

NCT ID: NCT01908751 Terminated - Clinical trials for Femoral Neck Fractures

Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)

FAITH-2
Start date: September 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the impact of surgical fixation (cancellous screws versus sliding hip screws) and biologic intervention (Vitamin D versus placebo) on patient important outcomes.

NCT ID: NCT01907802 Terminated - Renal Failure Clinical Trials

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Start date: August 23, 2013
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction. Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT01907100 Terminated - Mesothelioma Clinical Trials

Nintedanib (BIBF 1120) in Mesothelioma

Start date: September 19, 2013
Phase: Phase 2/Phase 3
Study type: Interventional

This is a phase II/III confirmatory study designed to evaluate the safety and efficacy of nintedanib (BIBF 1120) in combination + (pemetrexed / cisplatin) followed by nintedanib (BIBF 1120) versus placebo + pemetrexed / cisplatin followed by placebo for the treatment of patients with unresectable malignant pleural mesothelioma.

NCT ID: NCT01906957 Terminated - Metabolic Syndrome Clinical Trials

Cognition and Exercise Training

COGNEX-2
Start date: September 2013
Phase: N/A
Study type: Interventional

The aim of study is to investigate the impact of two different training modalities (high intensity interval training (HIIT) versus moderate intensity continuous exercise training (MICET) on cognitive performance, cerebral oxygenation, cardiac output and physical fitness in older healthy adults, patients with metabolic syndrome, coronary heart disease and heart failure. The investigators hypothesized that HIIT modality will lead to a larger improvement in physical fitness (i.e. VO2peak), cardiovascular parameters (cardiac output and stroke volume) and cognitive performance at rest and during submaximal exercise. The primary endpoint will be the improvement in cognitive performance.

NCT ID: NCT01905592 Terminated - Ovarian Neoplasms Clinical Trials

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

BRAVO
Start date: February 25, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare progression-free survival (PFS) in patients with advanced/metastatic breast cancer who have a BRCA mutation when treated with niraparib as compared to those treated with physician's choice

NCT ID: NCT01902810 Terminated - Burn Clinical Trials

Protective Effects of Propranolol in Adults

Start date: July 2013
Phase: Phase 2/Phase 3
Study type: Interventional

This efficacy and safety trial will examine the effects and safety of propranolol administered to adult patients with severe burn injury. The investigators hypothesize that propranolol will provide significant benefit to adults following severe burn injury at doses that are safe and do not increase risk of adverse infectious and non-infectious outcomes.

NCT ID: NCT01902290 Terminated - Asthma Clinical Trials

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility

Start date: May 22, 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if brodalumab (AMG 827) is safe and effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.

NCT ID: NCT01900665 Terminated - Alzheimer's Disease Clinical Trials

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

EXPEDITION 3
Start date: July 2013
Phase: Phase 3
Study type: Interventional

To test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.